| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |